Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Phase 1 Study Evaluating the Activity of Modular CAR T for mYeloma

NCT04795882 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04795882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Phase 1 Study Evaluating the Activity of Modular CAR T for mYeloma
Lead sponsor
University College, London
Phase
Phase 1
Overall status
Recruiting
Start date
April 22, 2022
Completion date
March 31, 2029
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma